Induction of graft-versus-host disease as immunotherapy of leukemia relapsing after allogeneic transplantation: Single-center experience of 32 adult patients

Bone Marrow Transplantation

Volumn 20, Issue 2, 1997, Pages 129-135

  Mehta, J ^a,b,c   Powles, R ^a   Kulkarni, S ^a   Treleaven, J ^a   Singhal, S ^a,b  

^a ROYAL MARSDEN HOSPITAL   (United Kingdom)

^b UNIVERSITY OF ARKANSAS FOR MEDICAL SCIENCES   (United States)

^c UNIVERSITY OF ARKANSAS FOR MEDICAL SCIENCES   (United States)

Author keywords

Acute leukemia; Chronic leukemia; Donor leukocyte infusion; Graft versus host disease; Graft versus leukemia; Immunotherapy

Indexed keywords

ALPHA2B INTERFERON; CYCLOSPORIN; INTERLEUKIN 2;

ACUTE LEUKEMIA; ADOLESCENT; ADULT; ALLOGENIC BONE MARROW TRANSPLANTATION; ANOREXIA; ARTICLE; BLAST CELL CRISIS; CANCER IMMUNOTHERAPY; CANCER MORTALITY; CANCER RECURRENCE; CANCER REGRESSION; CANCER SURVIVAL; CLINICAL ARTICLE; COUGHING; DIARRHEA; FEMALE; FEVER; GRAFT VERSUS HOST REACTION; HUMAN; HYPOTENSION; LEUKEMIA; LUNG INFILTRATE; MALE; NAUSEA; PRIORITY JOURNAL; SIBLING; SUBCUTANEOUS DRUG ADMINISTRATION; WHEEZING;

EID: 0030738037     PISSN: 02683369     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.bmt.1700859     Document Type: Article

References (28)

1. Mehta J, Powles R, Treleaven J et al. Outcome of acute leukemia relapsing after bone marrow transplantation: utility of second transplants and adoptive immunotherapy. Bone Marrow Transplant 1997 (in press).
2. Mehta J. Graft-versus-leukemia reactions in clinical bone marrow transplantation. Leuk Lymphoma 1993; 10: 427-432.
3. Slavin S, Or R, Naparstek E et al. Cellular mediated immunotherapy of leukemia in conjunction with autologous and allogeneic bone marrow transplantation in experimental animals and man. Blood 1988, 72 (Suppl. 1): 407a.
4. Komori T, Sugiyama H, Ogawa H et al. Treatment of a patient in a relapse after bone marrow transplantation for acute lymphoblastic leukemia with the systemic administration of allogeneic lymphokine-activated killer cells and recombinant hiterleukin-2. Eur J Haematol 1989; 43: 184-185.
5. Kolb HJ, Mittermüller J, Clemm C et al. Donor leukocyte transfusions for treatment of recurrent chronic myelogenous leukemia in marrow transplant patients. Blood 1990; 76: 2462-2465.
6. Collins RH Jr, Rogers ZR, Bennett M et al. Hematologic relapse of chronic myelogenous leukemia following allogeneic bone marrow transplantation: apparent graft-versus-leukemia effect following abrupt discontinuation of immunosuppression. Bone Marrow Transplant 1992; 10: 391-395.
7. Szer J, Grigg AP, Phillips GL, Sheridan WP. Donor leucocyte infusions after chemotherapy for patients relapsing with acute leukaemia following allogeneic BMT. Bone Marrow Transplant 1993; 11: 109-111.
8. Porter DL, Roth MS, McGarigle C et al. Induction of graftversus-host disease as immunotherapy for relapsed chronic myeloid leukemia. New Engl J Med 1994; 330: 100-106.
9. Van Rhee E, Lin F, Cullis JO et al. Relapse of chronic myeloid leukemia after allogeneic bone marrow transplant: the case for giving donor leukocyte transfusions before the onset of hematologic relapse. Blood 1994: 83: 3377-3383.
10. Mehta J, Powles R, Singhal S et al. Cytokine-mediated immunotherapy with or without donor leukocytes for poor-risk acute myeloid leukemia relapsing after allogeneic bone marrow transplantation. Bone Marrow Transplant 1995; 16: 133-137.
11. Kolb HJ, Schattenberg A, Goldman JM et al. Graft-versus-leukemia effect of donor lymphocyte transfusions in marrow grafted patients. Blood 1995; 86: 2041-2050.
12. Mehta J, Powles R, Singhai S et al. Clinical and hematologic response of chronic lymphocytic and prolymphocytie leukemia persisting after allogeneic bone marrow transplantation with the onset of acute graft-versus-host disease: possible role of graft-versus-leukemia. Bone Marrow Transplant 1996; 17: 371-375.
13. Slavin S, Naparstek E, Nagler A et al. Allogeneic cell therapy with donor peripheral blood cells and recombintint human interleukin-2 to treat leukemia relapse after allogeneic bone marrow transplantation. Blood 1996; 87: 2195-2204.
14. Mackinnon S, Papadopoulos EB, Carabasi MH et al. Adoptive immunotherapy evaluating escalating doses of donor leukocytes for relapse of chronic myeloid leukemia after bone marrow transplantation: separation of graft-versus-leukemia responses from graft-versus-host disease. Blood 1995; 86: 1261-1268.
15. Slavin S, Naparstek E, Nagler A et al. Allogeneic cell therapy: the treatment of choice for all hematologic malignancies relapsing post BMT. Blood 1996; 87: 4011-4013.
16. Mehta J, Powles RL, Mitchell P et al. Graft failure after bone marrow transplantation from unrelated donors using busulphan and cyclophosphamide for conditioning. Bone Marrow Transplant 1994; 13: 583-587.
17. Mehta J, Powles R, Horton C et al. Bone marrow transplantation for primary refractory acute leukaemia. Bone Marrow Transplant 1994; 14: 415-418.
18. Singhal S, Powles R, Treleaven J et al. Cell yields in a doubleblind randomized study of allogeneic marrow versus blood stem cell transplantation. Blood 1996; 88 (Suppl. 1): 403a.
19. Glucksberg H, Storb R, Fefer A et al. Clinical manifestations of graft-versus-host disease in human recipients of marrow from HL-A-matched sibling donors. Transplantation 1974; 18: 295-304.
20. Sullivan KM, Witherspoon RP, Storb R et al. Alternating-day cyctosporine and prednisone for treatment of high-risk chronic graft-v-host disease. Blood 1988: 72: 555-561.
21. Singhal S, Powles R, Treleaven J, Melitu J. Sensitivity of secondary acute myeloid leukemia relapsing after allogeneic bone marrow transplantation to immunotherapy with interferonα2b. Bone Marrow Transplant 1997 (in press).
22. Dunlop L, Powles R, Singhal S et al. Bone marrow transplantation for Philadelphia chromosome-positive acute lymphoblastic leukemia. Bone Marrow Transplant 1996; 17: 365-369.
23. Singhal S, Powles R, Treleaven J et al. Central nervous system relapse after bone marrow transplantation for acute leukemia in first remission. Bone Marrow Transplant 1996; 17: 637-641.
24. Horowitz MM, Gale RP, Sondel PM et al. Graft-versus-leuke-mia reactions after bone marrow transplantation. Blood 1990: 75: 555-562.
25. Marmont AM, Horowitz MM, Gale RP et al. T-cell depletion of HLA-identical transplants in leukemia. Blood 1991: 78: 2120-2130.
26. Naparstek E, Or R, Nagler A et al. T cell-depleted allogeneic bone marrow transplantation for acute leukaemia using Campath-1 antibodies and post-transplant administration of donor's peripheral blood lymphocytes for prevention of relapse. Br J Haematol 1995; 89: 506-515.
27. Meyers JD, Flournoy N, Sanders JE et al. Prophylactic use of human leukocyte interferon after allogeneic marrow transplantation. Ann Intern Med 1987; 107: 809-816.
28. Powles R, Treleaven J, Singhal S et al. Early lymphocyte recovery after allografting for acute myeloid leukemia and risk of relapse: identification of patients who may benefit from prophylactic immunotherapy. Blood 1996; 88 (Suppl. 1): 681a.